Showing 1-3 of 3

Sorted By:

  • Colon Cancer: CTSU 80702 (Iowa Cancer Specialists)

    This randomized phase III trial is studying giving patients oxaliplatin, leucovorin, and 5-fluorouracil (5-FU) together to compare how well they work when given together with or without celecoxib in treating patients with stage III colon cancer previously treated with surgery.

  • Colon Cancer: CTSU E5202 (Hematology Oncology Associates)

    This study will also compare the effects (good and bad) of a combination of chemotherapy drugs, when given with and without a new drug, bevacizumab, on patients with stage II colon cancer at high-risk for recurrence.

  • Colon Cancer: CTSU E5202 (Iowa Cancer Specialists)

    This study will also compare the effects (good and bad) of a combination of chemotherapy drugs, when given with and without a new drug, bevacizumab, on patients with stage II colon cancer at high-risk for recurrence.

Page InfoPage
Showing trials 1-3 of 3

View Additional Section Content

Contact Us

For more information about our research program and IRB, please contact:

Research Support Office
563-421-7955

Email